Literature DB >> 15106738

Prevention of bone loss in ovariectomized rats: the effect of Salvia miltiorrhiza extracts.

H J Chae1, S W Chae, D H Yun, K S Keum, S K Yoo, H R Kim.   

Abstract

The preventive effect of Salvia miltiorrhiza extracts (SMEs) on the progress of bone loss induced by ovariectomy (OVX) was studied in rats. We measured body weight and bone histomorphometry in sham, OVX or SMEs-administered OVX rats. From light microscopic analyses, a porous or erosive appearances were observed on the surface of trabecular bone of tibia in OVX rats, whereas those of the same bone in sham rats and in SMEs-administered rats were composed of fine particles. The trabecular bone area and trabecular thickness in OVX rats decreased by 50% from those in sham rats, these decreases were completely inhibited by administration of SMEs for 7 weeks. In this study, the mechanical strength in femur neck was significantly enhanced by the treatment of SMEs for 7 weeks. In OVX rats, free T3 was normal in all cases, whereas free T4 was significantly increased. Although there was no difference between OVX and SMEs-administered rats in T3 level, we have found significant difference between them in T4 level. These results strongly suggest that SMEs are effective in preventing the development of bone loss induced by OVX in rats.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15106738     DOI: 10.1081/iph-120029951

Source DB:  PubMed          Journal:  Immunopharmacol Immunotoxicol        ISSN: 0892-3973            Impact factor:   2.730


  9 in total

1.  Simultaneous detection of seven phenolic acids in Danshen injection using HPLC with ultraviolet detector.

Authors:  Jin-zhong Xu; Jie Shen; Yi-yu Cheng; Hai-bin Qu
Journal:  J Zhejiang Univ Sci B       Date:  2008-09       Impact factor: 3.066

2.  Tanshinones that selectively block the collagenase activity of cathepsin K provide a novel class of ectosteric antiresorptive agents for bone.

Authors:  Preety Panwar; Simon Law; Andrew Jamroz; Pouya Azizi; Dongwei Zhang; Marco Ciufolini; Dieter Brömme
Journal:  Br J Pharmacol       Date:  2018-02-09       Impact factor: 8.739

3.  The theoretical and experimental study on dicalcium phosphate dehydrate loading with protocatechuic aldehyde.

Authors:  Yuehua Guo; Shuxin Qu; Xiong Lu; Haodong Xie; Hongping Zhang; Jie Weng
Journal:  J Mol Model       Date:  2009-12-18       Impact factor: 1.810

4.  Simultaneous Determination and Pharmacokinetic Study of Protocatechuic Aldehyde and Its Major Active Metabolite Protocatechuic Acid in Rat Plasma by Liquid Chromatography-Tandem Mass Spectrometry.

Authors:  Xiangyang Wang; Kaijing Yan; Xiaohui Ma; Wei Li; Yang Chu; Jiahua Guo; Shuming Li; Shuiping Zhou; Yonghong Zhu; Changxiao Liu
Journal:  J Chromatogr Sci       Date:  2016-03-10       Impact factor: 1.618

5.  Characterization of Salvia miltiorrhiza ethanol extract as an anti-osteoporotic agent.

Authors:  Yan Cui; Bidur Bhandary; Anu Marahatta; Geum-Hwa Lee; Bo Li; Do-Sung Kim; Soo-Wan Chae; Hyung-Ryong Kim; Han-Jung Chae
Journal:  BMC Complement Altern Med       Date:  2011-11-28       Impact factor: 3.659

Review 6.  Natural Products from Chinese Medicines with Potential Benefits to Bone Health.

Authors:  Chun-Tao Che; Man Sau Wong; Christopher Wai Kei Lam
Journal:  Molecules       Date:  2016-02-27       Impact factor: 4.411

7.  Effects of Salvia miltiorrhiza ethanolic extract on lipopolysaccharide-induced dental alveolar bone resorption in rats.

Authors:  Huang-Tzu Tsai; Wen-Liang Chang; Hsiao-Pei Tu; Earl Fu; Yao-Dung Hsieh; Cheng-Yang Chiang
Journal:  J Dent Sci       Date:  2015-09-09       Impact factor: 2.080

8.  Sal B targets TAZ to facilitate osteogenesis and reduce adipogenesis through MEK-ERK pathway.

Authors:  Na Wang; Yukun Li; Ziyi Li; Chang Liu; Peng Xue
Journal:  J Cell Mol Med       Date:  2019-03-25       Impact factor: 5.310

9.  Potential antiosteoporotic agents from plants: a comprehensive review.

Authors:  Min Jia; Yan Nie; Da-Peng Cao; Yun-Yun Xue; Jie-Si Wang; Lu Zhao; Khalid Rahman; Qiao-Yan Zhang; Lu-Ping Qin
Journal:  Evid Based Complement Alternat Med       Date:  2012-12-31       Impact factor: 2.629

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.